Keratosis Pilaris Revisited: Is It More Than Just a Follicular Keratosis?

Nilotinib-Induced Keratosis Pilaris

Nilotinib is a second-generation Bcr-Abl tyrosine kinase inhibitor (TKI) that is approved for the treatment of imatinib-resistant chronic myeloid leukaemia expressing the Bcr-Abl mutation. Cutaneous adverse drug reactions occur more frequently in patients using this medication. We present a case of nilotinib-induced keratosis pilaris that did not have accompanying symptoms of alopecia or prurit...

Inverted follicular keratosis = نارقتلا يبارجلا بولقملا INVERTED FOLLICULAR KERATOSIS

Inverted Follicular Keratosis Scalp

Inverted follicular keratosis (IFK) is a solitary benign epithelial tumor of infundibular hair follicle, generally observed in middle-aged and older individuals. An elderly male presented with a rough & raised pink colored lesion on the bald area of parietal scalp since 4 months. Fine needle aspiration (FNA) followed by histopathologic examination of the lesion was done. The FNA smears revealed...

Inverted follicular keratosis.

We reviewed 17 cases of inverted follicular keratosis. The median age of the patients at the time of surgery was 69 years. Follow-up in 14 cases showed no recurrences of inverted follicular keratosis, which is a benign skin lesion, often mistaken clinically and pathologically for a malignancy. Inverted follicular keratosis is characterized histologically by the presence of squamous eddies, acan...

Epidermal Permeability Barrier in the Treatment of Keratosis Pilaris

Objectives. To evaluate and compare the efficacy, safety, hydrating properties, and tolerability of 10% lactic acid (LA) and 5% salicylic acid (SA) in the therapy of keratosis pilaris (KP). Material and Method. Patients with KP were randomized for treatment with either 10% LA or 5% SA creams being applied twice daily for 3 months. The patients were clinically assessed at baseline and after 4, 8...